The Flinn Foundation provides grants to Arizona universities, nonprofit research institutions, health systems, and others to strengthen the state’s bioscience and biomedical-research infrastructure and advance collaborative research.
By promoting research, entrepreneurship, and partnerships across the state’s bioscience ecosystem, the Flinn Foundation’s bioscience grantmaking program advances the research and commercialization goals of the new Arizona’s Bioscience Roadmap.
Major Foundation grants funded research to address the problem of chronic rhinosinusitis; develop a medical-nutrition program for health-care providers; improve providers’ capacity to use pharmacogenetic testing to guide safe and effective prescribing of medicines; and develop a framework for health-care providers to respond to antimicrobial resistance.
The Flinn Foundation Translational Seed Grants Program, which awards $100,000 grants annually for up to 10 research teams at universities, nonprofit research institutes, and hospitals, is designed to translate innovations and discoveries into patient care more quickly. Bringing together academic scientists and clinicians, the program’s collaborative projects have focused on brain injuries and cancer, ALS, melanoma, colorectal and bladder cancer, West Nile virus, asthma, autism, Valley fever, antivenom, Barrett’s Esophagus, and other areas of clinical importance. Three projects from each cohort are eligible for $100,000 in new, follow-on funding.
The seed grants program, which comprises about a third of the Foundation’s research funds, has awarded 90 seed grants totaling about $10.2 million since 2013. The initiative enables organizations to better compete for larger grants from funders like the National Institutes of Health or build partnerships to facilitate commercialization.
Since 2014, the Flinn Foundation has selected 66 Arizona bioscience companies in a competitive process to receive funding through the Bioscience Entrepreneurship Program. The program’s nonprofit partners have provided more than $2.1 million over 12 cohorts.
Each Flinn Foundation Bioscience Entrepreneurship Program selectee receives $75,000 in funding support, administered through the Foundation’s nonprofit partner, the Arizona Bioindustry Association, plus programmatic benefits over the year-long program. The applications for both revamped programs will open Monday, Aug. 3.
Subscribe to Arizona Bioscience News for the latest sector developments. ➤
